The ADMIT series - issues in inhalation therapy. 5) Inhaler selection in children with asthma

Primary Care Respiratory Journal

Volumn 19, Issue 3, 2010, Pages 209-216

  Pedersen, Søren ^a,c   Dubus, Jean Christophe ^b,c   Crompton, Graham ^c   Barnes, Peter J ^c   Broeders, Mariëlle ^c   Corrigan, Chris ^c   Corbetta, Lorenzo ^c   Dekhuijzen, Richard ^c   Hausen, Thomas ^c   Kneussl, Meinhard ^c   Lavorini, Federico ^c   Levy, Mark L ^c   de Almeida, Antonio Ramalho ^c   Sanchis, Joaquin ^c   Viejo, Jose L ^d   Vincke, Walter ^c   Voshaar, Thomas ^c  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b TIMONE HOSPITAL   (France)

^c Hospital General Yagüe de Burgos ^*

^d HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

Author keywords

Asthma; Children; Inhalation technique; Inhalation therapy; Inhaler selection

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHLOROFLUOROCARBON; CICLESONIDE; CORTICOSTEROID; FLUTICASONE FUROATE; FLUTICASONE PROPIONATE; MOMETASONE FUROATE; NORFLURANE; TRIAMCINOLONE;

AEROSOL; ASTHMA; CHILD; CHILD CARE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG MEGADOSE; DRUG METABOLISM; HUMAN; INHALATION SPACER; INHALER; METERED DOSE INHALER; PARTICLE SIZE; PATIENT EDUCATION; POWDER INHALER; REVIEW;

ADOLESCENT; AGE FACTORS; ANTI-ASTHMATIC AGENTS; ASTHMA; CHILD; CHILD, PRESCHOOL; DRY POWDER INHALERS; HUMANS; INFANT; INHALATION SPACERS; METERED DOSE INHALERS; NEBULIZERS AND VAPORIZERS; PATIENT EDUCATION AS TOPIC;

EID: 77957605146     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2010.00043     Document Type: Review

References (59)

1. Fuglsang G, Hertz B, Holm B. No protection by oral terbutaline against exerciseinduced asthma in children: a dose response study. Eur Respir J 1993;6:527-30.
2. Newhouse MT, Ruffin RE. Deposition and fate of aerosolized drugs. Chest 1978;73(6 Suppl):936-43.
3. Dolovich M, Ruffin RE, Roberts R, Newhouse MT. Optimal delivery of aerosols from metered dose inhalers. Chest 1981;80(6 Suppl):911-15.
4. Dolovich MB, Ahrens RC, Hess DR, et al. Device selection and outcomes of aerosol therapy: Evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest 2005;127(1):335-71. http://dx.doi.org/10.1378/chest.127.1.335
5. Brand PL. Key issues in inhalation therapy in children. Curr Med Res Opin 2005;21 Suppl 4:S27-32. http://dx.doi.org/10.1185/030079905X61767
6. Everard ML. Guidelines for devices and choices. J Aerosol Med 2001;14 Suppl 1:S59-64. http://dx.doi.org/10.1089/08942680150506358
7. Kamps AW, van EB, Roorda RJ, Brand PL. Poor inhalation technique, even after inhalation instructions, in children with asthma. Pediatr Pulmonol 2000;29(1):39-42. http://dx.doi.org/10.1002/SICI)1099-0496(200001)29:139::AID-PPUL73.3.CO;2-7
8. Gracia-Antequera M, Morales Suarez-Varela M. An intervention to improve the inhalatory technique of children and adolescents with asthma. Allergol Immunopathol (Madr) 1999;27(5):255-60.
9. De BK, Alifier M, Warnier G. Is the correct use of a dry powder inhaler (Turbohaler) age dependent? J Allergy Clin Immunol 1999;103(5 Pt 1):763-7.
10. Pedersen S, Mortensen S. Use of different inhalation devices in children. Lung 1990;168 Suppl:653-7. http://dx.doi.org/10.1007/BF02718190
11. Pedersen S, Frost L, Arnfred T. Errors in inhalation thechnique and efficacy of inhaler use in asthmatic children. Allergy 1986;41:118-24. http://dx.doi.org/10.1111/j.1398-9995.1986.tb00287.x.
12. Pedersen S. Inhaler use in children with asthma. Danish Med Bull 1987;34:234-49.
13. Newman S, Pavia D, Morén F, Sheahan NF, Clarke SW. Deposition of pressurized aerosols in the human respiratory tracts. Thorax 1981;36:52-5. http://dx.doi.org/10.1136/thx.36.1.52
14. Dolovich M, Coates G, Hargreave F, Newhouse MT. Aerosols in diagnosis: ventilation, airway penetrance, aireay reactivity, epithelial permeability and mucociliary transport. In: Moren F, Newhouse MT, Dolovich M, editors. Aerosols in Medicine. Principles, Diagnosis, and Therapy. Amsterdam: Elsevier Science Publishers; 1985. p. 225-59.
15. Olsson B, Borgström L, Asking L, Bondesson E. Effect of inlet throat on the correlation between measured fine particles dose and lung deposition. 1996;- In Dalby R, Byron P, Farr S, eds. Respiratory Drug Delivery V Buffalo Grove, IL: Interpharm Press, 1996:273-81.
16. Agertoft L, Andersen A, Weibull E, Pedersen S. Systemic availability and pharmacokinetics of nebulized budesonide in pre-school children with asthma. Arch Dis Child 1999;80:241-7. http://dx.doi.org/10.1136/adc.80.3.241
17. Agertoft L, Pedersen S, Harrison L. Lung deposition and basic pharmacokinetic parameters of beclomethasone dipropionate in asthmatic children after inhalation from a HFA-pMDI (Autohaler) and a CFC-pMDI with spacer. Am J Respir Crit Care Med 1999;159(No 3 Pt 2):A120.
18. Roller CM, Zhang G, Troedson RG, Leach CL, Le Souef PN, Devadason SG. Spacer inhalation technique and deposition of extrafine aerosol in asthmatic children. Eur Respir J 2007;29(2):299-306. http://dx.doi.org/10.1183/09031936.00051106
19. Wildhaber JH, Devadason SG, Wilson JM, et al. Lung deposition of budesonide from turbuhaler in asthmatic children. Eur J Pediatr 1998;157(12):1017-22. http://dx.doi.org/10.1007/s004310050990
20. Devadason SG, Everard ML, MacEarlan C, et al. Lung deposition from the Turbuhaler in children with cystic fibrosis. Eur Respir J 1997;10(9):2023-8.
21. Wildhaber JH, Janssens HM, Pierart F, Dore ND, Devadason SG, LeSouef PN. High-percentage lung delivery in children from detergent-treated spacers. Pediatr Pulmonol 2000;29(5):389-93. http://dx.doi.org/10.1002/SICI)1099-0496(200005)29:5389::AID-PPUL83.0.CO;2-3
22. Prahl P, Jensen T. Decreased adrenocortical suppression utilizing the Nebuhaler for inhalation of steroid aerosols. Clin Allergy 1987;17:393-8. http://dx.doi.org/10.1111/j.1365-2222.1987.tb02031.x.
23. Brown PH, Blundell G, Greening AP, Crompton GK. Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids? Thorax 1990;45:736-9. http://dx.doi.org/10.1136/thx.45.10.736
24. Selroos O, Halme M. Effect of a volumatic spacer and mouth-rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and a dry powder inhaler. Thorax 1991;46:891-4. http://dx.doi.org/10.1136/thx.46.12.891
25. Hendeles L, Colice GL, Meyer RJ. Withdrawal of albuterol inhalers containing chlorofluorocarbon propellants. N Engl J Med 2007;356(13):1344-51. http://dx.doi.org/10.1056/NEJMra050380
26. Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir Care 2005;50(10):1360-74.
27. Rubin BK, Fink JB. Optimizing aerosol delivery by pressurized metered-dose inhalers. Respir Care 2005;50(9):1191-200.
28. Pedersen S, Østergaard P. Nasal inhalation as a cause of inefficient pulmonary aerosol inhalation thechnique in children. Allergy 1983;38:191-4. http://dx.doi.org/10.1111/j.1398-9995.1983.tb01605.x.
29. Newman SP, Pavia D, Clarke SW. How should a pressurized beta-adrenergic bronchodilator be inhaled? Eur J Respir Dis 1981;62(1):3-21.
30. Ruggins NR, Milner AD, Swarbrick A. An assessment of a new breath actuated inhaler device in acutely wheezy children. Arch Dis Child 1993;68:477-80. http://dx.doi.org/10.1136/adc.68.4.477
31. Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir Care 2005;50(10):1360-74.
32. Mitchell JP, Nagel MW. Valved holding chambers (VHCs) for use with pressurised metered-dose inhalers (pMDIs): a review of causes of inconsistent medication delivery. Prim Care Resp J 2007;16(4):207-14. http://dx.doi.org/10.3132/pcrj.2007.00034
33. Kamps AW, Brand PL, Roorda RJ. Determinants of correct inhalation technique in children attending a hospital-based asthma clinic. Acta Paediatr 2002;91(2):159-63. http://dx.doi.org/10.1080/080352502317285144
34. Castro-Rodriguez JA, Rodrigo GJ. Beta-agonists through metered-dose inhaler with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: a systematic review with meta-analysis. J Pediatr 2004;145(2):172-7. http://dx.doi.org/10.1016/j.jpeds.2004.04.007
35. Gleeson JG, Price J. Nebuhaler technique. Br J Dis Chest 1988;82:172-4. http://dx.doi.org/10.1016/0007-0971(88)90039-3
36. Crompton GK, Barnes PJ, Broeders M, et al. The need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement Team. Respir Med 2006;100(9):1479-94. http://dx.doi.org/10.1016/j.rmed.2006.01.008
37. Newman S, Millar A, Lennard-Jones T, Moren F, Clarke SW. Improvement of pressurised aerosol deposition with nebuhaler spacer device. Thorax 1984;39:935-41. http://dx.doi.org/10.1136/thx.39.12.935
38. Clark AR, Rachelefsky G, Mason PL, Goldenhersh MJ, Hollingworth A. The use of reservoir devices for the simultaneous delivery of two metered-dose aerosols. J Allergy Clin Immunol 1990;85:75-9.
39. Agertoft L, Pedersen S. Influence of spacer device on drug delivery to young children with asthma. Arch Dis Child 1994;71:217-20. http://dx.doi.org/10.1136/adc.71.3.217
40. Mitchell JP, Coppolo DP, Nagel MW. Electrostatics and inhaled medications: influence on delivery via pressurized metered-dose inhalers and add-on devices. Respir Care 2007;52(3):283-300.
41. Janssens HM, Devadason SG, Hop WC, LeSouef PN, de Jongste JC, Tiddens HA. Variability of aerosol delivery via spacer devices in young asthmatic children in daily life. Eur Respir J 1999;13(4):787-91.
42. Köhler D, Fleicher W. Established facts of inhalation therapy: a review of aerosol therapy and commonly used drugs. Lung & Respiratory 1989;6:1-16.
43. Richards R, Dickson CR, Renwick AG, Lewis RA, Holgate S. Absorption and disposition kinetics of cromolyn sodium and the influence of inhalation technique. J Pharmacol Exp Ther 1987;241(3):1028-32.
44. Prime D, Grant AC, Slater AL, Woodhouse RN. A critical comparison of the dose delivery characteristics of four alternative inhalation devices delivering salbutamol: pressurized metered dose inhaler, Diskus inhaler, Diskhaler inhaler, and Turbuhaler inhaler. J Aerosol Med 1999;12(2):75-84. http://dx.doi.org/10.1089/jam.1999.12.75
45. Nielsen KG, Skov M, Klug B, Ifversen M, Bisgaard H. Flow-dependent effect of formoterol dry-powder inhaled from the Aerolizer. Eur Respir J 1997;10:2105-09.
46. Olsson B. Aerosol particle generation from dry powder inhalers: can they equal pressurized metered dose inhalers? J Aerosol Med 1995;8 (suppl 3):13-9. http://dx.doi.org/10.1089/jam.1995.8.Suppl_3.S-13
47. Olsson B, Asking L. Critical aspects of the function of inspiratory flow driven inhalers. J Aerosol Med 1994;7(Suppl 1):S43-7. http://dx.doi.org/10.1089/jam.1994.7.Suppl_1.S-43
48. Martin RJ, Szefler SJ, Chinchilli VM, et al. Systemic effect comparisons of six inhaled corticosteroid preparations. Am J Respir Crit Care Med 2002;165(10):1377-83. http://dx.doi.org/10.1164/rccm.2105013
49. Agertoft L, Pedersen S. Lung deposition and systemic availability of fluticasone Diskus and budesonide Turbuhaler in children. Am J Respir Crit Care Med 2003;168(7):779-82. http://dx.doi.org/10.1164/rccm.200302-200OC
50. Zainudin BMZ, Biddiscombe M, Tolfree SEJ, Short M, Spiro SG. Comparison of bronchodilator responses and deposition patterns of salbutamol inhaled from a pressurised metered dose inhaler, as a dry powder, and as nebulised solution. Thorax 1990;45:469-73. http://dx.doi.org/10.1136/thx.45.6.469
51. Biddiscombe M, Marriott RJ, Melchor R, Short M, Spiro SG, Taylor AJ. The preparation and evaluation of pressurized metered dose and dry powder inhalers containing 99mTc labelled salbutamol. J Aer Med 1991;4 (suppl 1):9-12.
52. Khassawneh BY, Al-Ali MK, Alzoubi KH, et al. Handling of inhaler devices in actual pulmonary practice: metered-dose inhaler versus dry powder inhalers. Respir Care 2008;53(3):324-8.
53. Wieshammer S, Dreyhaupt J. Dry powder inhalers: which factors determine the frequency of handling errors? Respiration 2008;75(1):18-25. http://dx.doi.org/10.1159/000109374
54. Malot L, Molimard M, Abouelfatah A, et al. [Assessment of the handling of inhaler devices: an observational study of children in primary care]. Arch Pediatr 2007;14(10):1190-5. http://dx.doi.org/10.1016/j.arcped.2007.06.017
55. Molimard M. How to achieve good compliance and adherence with inhalation therapy. Curr Med Res Opin 2005;21 Suppl 4:S33-7. http://dx.doi.org/10.1185/030079905X61776
56. Agertoft L, Pedersen S. Importance of training for correct Turbuhaler use in preschool children. Acta Pædiatr Scand 1998;87:842-7. http://dx.doi.org/10.1080/080352598750013608
57. Young PM, Price R, Tobyn MJ, Buttrum M, Dey F. Investigation into the effect of humidity on drug-drug interactions using the atomic force microscope. J Pharm Sci 2003;92(4):815-22. http://dx.doi.org/10.1002/jps.10250
58. Price R, Young PM, Edge S, Staniforth JN. The influence of relative humidity on particulate interactions in carrier-based dry powder inhaler formulations. Int J Pharm 2002;246(1-2):47-59. http://dx.doi.org/10.1016/S0378-5173(02)00359-9
59. Kamps AW, Brand PL, Kimpen JL, et al. Outpatient management of childhood asthma by paediatrician or asthma nurse: randomised controlled study with one year follow up. Thorax 2003;58(11):968-73. http://dx.doi.org/10.1136/ thorax.58.11.968